Introduction {#s0005}
============

It has been established that a variant of coronaviruses, SARS-CoV, is the pathogen of SARS [@bib1]. The N protein (nucleoprotein) is one of the major structural proteins in a viral particle, playing a critical role in the transcription regulation of the genomic RNA and other viral proteins [@bib2]. It might also be involved in the virulence and virus-specific post-translational modifications [@bib3].

In this paper, we report the predicted structure, possible functions, evolution, and the immunoassay of the N protein of SARS-CoV to confirm that the N protein is one of the major antigens with synthesized polypeptides.

Results and Discussion {#s0010}
======================

The ORF of the N protein {#s0015}
------------------------

The ORF (open-reading frame) for the N protein is located at the 3′ end (nucleotide position 28,101-29,369) of the SARS-CoV genome. The ORF is 1,269 nucleotide (nt) long, accounting for 4.27% of the total genome. It has a GC content of 48.38% (A: U: C: G = 31.60: 20.02: 26.32: 22.06), which is significantly higher than the average of the complete SARS-CoV genome (40.76%). And the GC content in the left half near the 5′ end (51.63%) is obviously higher than that in the right half near the 3′ end (44.68%) ([Figure 1](#f0005){ref-type="fig"}).

General physiochemical features of the N protein {#s0020}
------------------------------------------------

The N protein is composed of 422 amino acids (a.a.) with an estimated molecular weight of 46.03 KD, the second largest of the structural viral protein. It has a low percentage (\< 1.7%) of methionine, tryptophan and histidine residues, but does not contain any cysteine ([Table 1](#t0005){ref-type="table"}).

Absence of the cysteine is one of the common features in coronavirus N proteins. Cysteine is an important amino acid in zinc knuckle structure that may be involved in packaging signal recognition [@bib4]. It has been reported that the N protein of MHV (murine hepatitis virus) has no any known RNA-binding motif, such as arginine-rich motif or zinc finger [@bib5]. The lack of cysteine in the N protein of SARS-CoV indicates that the interaction of the N protein and signal packaging may occur in the absence of zinc knuckle structure.

The complete N protein is a highly basic protein. It has positively net charges, and has the highest pI (pI 10.11) among all known structural proteins in the virus, making it easier to interact with acidic genomic RNA. The charge distribution shows five positive peaks with relatively even distance ([Figure 1](#f0005){ref-type="fig"}). Positively charged amino acids, histidine, lysine and arginine, account for a big portion in each peak. In addition to high pI and positive charges, the N protein has a high hydrophilicity (54%). The middle of the N protein is relatively hydrophobic, but the two termini are hydrophilic ([Figure 1](#f0005){ref-type="fig"}). The N-terminus is basic with positive charge, while the C-terminus is acidic with negative charge. In a model for demonstrating the interaction of multiple N proteins, the two termini are supposed to be linked end to end [@bib6].

Phosphorylation of the N protein {#s0025}
--------------------------------

Phosphorylation of the N protein is related to RNA-binding, oligomerization and localization to nucleoli [@bib3]. We identified 33 potential phosphorylation sites in the N protein, including 22 serines, 8 threonines and 3 tyrosines. The average score of serines is the highest among the three amino acids. This demonstrates that serines are the predominant phosphorylated residues in the N protein, consistent with the previous reports [@bib5]. The phosphorylation sites concentrate in the middle of the N protein ([Figure 2](#f0010){ref-type="fig"}). However, the exact number and location of phosphoserines have not been identified by experiments yet.

Structure of the N protein {#s0030}
--------------------------

Through multi-alignment of total nineteen sequences of the coronavirus N proteins, we found two conserved structural regions at Codons 81-140 and 270-320 (a.a. positions are all referred to the N protein of SARS-CoV, Isolate BJ01), with the former more conserved ([Figure 3](#f0015){ref-type="fig"}). This result is consistent with the conserved domains that we have predicted by using CDS (Conserved Domain Search). A highly conserved domain (FYYLGTGP at Codons 111-118) was identified within the first conserved region in all coronaviruses. These conserved regions and domains could serve as potential drug targets because of their great possibility of performing critical functions. In contrast, the two termini of the N protein are more variable, particularly the C-terminus.

We also predicted the secondary structure of the N protein by using PSIPRED. According to the result, the N protein is composed of coils, strands, and helices. There are totally eight helices and seven of them are distributed in the 3′ end of the N protein.

SR-rich region of the N protein {#s0035}
-------------------------------

An SR-rich region (a region rich of serine and arginine) was identified in the coronavirus N protein, which has a core motif of SR{X~2~}SR{X~2~}SR (X indicates any amino acid, and subscript number indicates the number of amino acids between two SRs.). In the N protein of SARS-CoV, its SR-rich region presents a symmetric structure: SR{X~6~}SR{X~2~}SRSR{X~2~}SR{X~6~}SR (Codons 177-204).

The SR-rich region has been found in all coronavirus N proteins. However, it is not within conserved regions that we have detected this region from similarity analysis. Further study showed that this region is relatively variable. For example, in the N protein of SARS-CoV, there is a substitution in SR-rich region. Therefore, we used SR as a marker to identify this region, though amino acid change may occur in SR and cause marker to disappear. We classified all SR-rich regions of coronavirus N proteins into a few types ([Table 2](#t0010){ref-type="table"}), and discovered that the classification of those coronaviruses by their core motifs of the SR-rich region was consistent with the phylogenic tree that we had constructed. It seems that the SR-rich region is typically common and representative, though it is outside the conserved regions and has easily-varied sequence.

Previous study reported that the N protein of MHV could interact with the M (membrane) protein to help the envelopment of MHV nucleocapsid [@bib7]. By targeting RNA recombination, Ding, *et al*. found that the SR-rich region could not be transferred from MHV to BCoV (bovine coronavirus), which means that this region was unable to be substituted between various species [@bib6]. It is believed that the SR-rich region is possibly derived from the SR (or RS) domain of many RNA-binding proteins, such as SR proteins [@bib6]. The SR proteins are essential for constitutive mRNA splicing and the regulation of alternative splice site selection [@bib8]. The C-terminal SR domain of SR proteins is involved in mediating protein-protein interaction as well as nuclear localization [@bib8], [@bib9]. The SR-rich region might be necessary for the interaction of the N and M proteins. It also possibly contributes to the interaction of the N protein with other viral proteins, including the N protein itself.

Localization to the nucleolus is a common feature of coronavirus N proteins. This feature helps with disrupting host cell division to promote virus assembly and sequestering ribosomes for translation of viral proteins [@bib10]. It has been reported that the SR domain in SR proteins is a nuclear localization signal but not a subnuclear speckle one [@bib8]. Consequently, the SR-rich region may function only as a nuclear localization signal. Subnuclear localization of the N protein might need several additive and redundant signals. InterproScan has revealed that there is a bipartite nuclear localization signal domain (NLS-BP, IPR001472) in the N protein, which has a sequence of KKKKTDEAQPLPQRQKKQ at Codons 373-390. NLS-BP is a domain for the protein translocation from cytoplasm to nucleus.

Phosphorylation and dephosphorylation of the SR domain in SR proteins are necessary for its function. We also detected that in the N protein, the SR-rich region has eleven possible phosphoserines, which account for 50% of the total. This indicates that the SR-rich region is an important region involved in phosphorylation and this post-transcription modification is greatly required for RNA-binding, oligomerization, and localization to nucleoli of the N protein.

Prediction and immunoassay confirmation of antigenic sites of the N protein {#s0040}
---------------------------------------------------------------------------

Previous experiments showed that hydrophobic residues, such as cysteine, leucine and valine, on the surface of the protein are most likely to be part of antigenic determinants. Based on a semi-empirical method through making a statistics of appearance frequency of each amino acid in known segmental epitopes [@bib11], we have predicted 16 antigenic sites of the N protein and found they are clustering in the middle and the C-terminus ([Figure 4](#f0020){ref-type="fig"} and [Table 3](#t0015){ref-type="table"}). There is a strong antigenic site (TALALLLLDR) located around Codons 218-227. In addition, another three strong antigenic sites were detected around Codons 156-166 (AATVLQLPQGT), Codons 347-363 (FKDNVILLNKHIDAYKT) and Codons 389-398 (KQPTVTLLPA) ([Table 3](#t0015){ref-type="table"}).

To confirm the antigenicity of the N protein, we synthesized peptides of 20-25 amino acids covering the complete N protein. We designed fourteen peptides that are in the region of low conservativeness, excluding those of high conservativeness ([Table 4](#t0020){ref-type="table"}). By using sera samples of nine SARS patients with ELISA (enzyme-linked immunosorbent assay), We found that two out of fourteen peptides showed strong immunogenicity and seven peptides showed medium-strong immunogenicity ([Table 4](#t0020){ref-type="table"}).

Compared with the experimental outcome on immunogenicity of synthesized peptides, the predicted result about the antigenicity of the N protein is fairly reliable. Synthesized peptides containing the corresponding predicted antigenic sites showed strong or medium-strong immunogenicity, except for peptides N99 (Codons 99-120). This might because that its position is within the conserved region, which decreases the specificity of reaction. The different immunogenicity of peptides in different regions on the N protein is also consistent with the predicted antigenicity map.

It was reported that in the coronavirus-infected cells, the N protein was a more abundant antigen than the S (spike) protein [@bib12]. We also performed the same experiments on the S protein of SARS-CoV (see the article about the S protein in this issue). The comparison of both results demonstrates that the percentage of strongly positive results in the N protein (64%) is significantly higher than that in the S protein (28%). One of the explanations might be that the N protein is the most abundant protein produced throughout infection, because its template mRNA is the smallest and it has the most abundant sgRNA (subgenome RNA) during transcription [@bib2]. When the infected cells broke up and released the inside content, the N protein showed the strongest antigenicity. Combined with our prediction and experimental results, we believe that the N protein is a predominant antigen of SARS-CoV.

Evolution and substitution of the N protein {#s0045}
-------------------------------------------

Based on the nineteen coronavirus N proteins, we constructed an evolutionary tree ([Figure 5](#f0025){ref-type="fig"}). It reveals that SARS-CoV is closer to Group 2 than to Groups 1 and 3. We also performed a global pair-wise alignment of these nineteen sequences ([Table S1](#s0080){ref-type="sec"}). The N protein of SARS-CoV is highly similar to that of Equine coronavirus (49.8% similarity, 34.3% identity), with the lowest similarity to that of human coronavirus 229E strain (32.1% similarity, 21.2% identity).

To date there are seventeen isolates of SARS-CoV that have complete sequences. Only four substitutions have been identified in the N protein ([Table 5](#t0025){ref-type="table"}). The substitution rate of the N protein is 0.32%, lower than the average of SARS-CoV genome (0.46%). We suggest that the N protein is much more conserved than other structural proteins for its substitution rate is the lowest among all known proteins. These four substitutions resulted in the change of three codons. There are two substitutions juxtaposed within the same codon of leucine. One is at the second nucleotide of Codon 140 (nt position 28,519), leading to amino acid change from leucine to tryptophan, and the other is at the third nucleotide of Codon 140 (nt position 28,520) as a synonymous substitution.

Methods and Materials {#s0050}
=====================

Samples and sequences {#s0055}
---------------------

The SARS patients, from whom the genome sequences of Isolates BJ01-BJ04 were extracted, were diagnosed according to WHO guidelines (<http://www.who.int/csr/sars/guidelines/en/>) in February and March 2003 in Beijing, China. The processing of tissue samples and viral RNA, RT-PCR, cloning, and sequencing were performed according to standard protocols at Beijing Genomics Institute (BGI) and Center of Disease Control and Prevention of China [@bib13].

The updated complete genome sequences of the BJ Group (BJ01--BJ04) have been deposited by BGI in GenBank (accession numbers: AY278488, AY278487, AY278490, and AY279354) (<http://www.genomics.org.cn/bgi/news/zhongxin/news030416-2_fasta.htm>). All the sequences and experimental materials are available freely.

Thirteen other full-length sequences of SARS-CoV strains, which have been published by BGI or other laboratories since March 2003, have been used in this study (accession numbers: AY278554, AY297028, AY274119, AY291451, AY283798, AY283797, AY283796, AY283795, AY283794, AY282752, AY278741, AY278491, and AY278489). Nineteen coronavirus N protein sequences were downloaded from GenBank (accession numbers: AAP30037, NP_045302, CAD67607, AAF97743, AAG39339, NP_150083, AAL80036, P33469, AAD33104, AAF23872, NP_040838, P33463, NP_058428, Q04700, BAC65328, BAC01157, BAC01161, NP_073556, and NP_598314). The nucleotide positions of SARS-CoV are all referred to the complete genome sequence of Isolate BJ01 [@bib14].

Structure and function analysis {#s0060}
-------------------------------

ORF Finder (<http://ww.ncbi.nlm.nih.gov/gorf/gorf.html>) was used to determine ORFs, EMBOSS package (<http://www.hgmp.mrc.ac.uk/Software/EMBOSS/>) to characterize proteins, NetPhos (<http://www.cbs.dtu.dk/services/NetPhos/>) and PhosphoBase (<http://www.cbs.dtu.dk/databases/PhosphoBase/>) to predict phosphorylation sites, TopPred2 (<http://bioweb.pasteur.fr/seqanal/interfaces/toppred.html>) and ProtScale (<http://us.expasy.org/cgi-bin/protscale.pl>) to identify the hydrophobic region, ClustalW (<http://www-igbmc.u-strasbg.fr/BioInfo/ClustalW/>) to perform multiple-alignment and phylogenetic analysis, PSIPRED (<http://bioinf.cs.ucl.ac.uk/psiform.html>) to analyze secondary structures, InterproScan (<http://www.ebi.ac.uk/interpro/>) and CDS (Conserved Domain Search, <http://www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi>) to predict conserved protein domains. All the analyses were accomplished on supercomputers DOWNING 2000/3000 (DOWNING Computers Inc., Beijing, China), SUN E10K (SUN Microsystems Inc., California, USA), SGI Origin 3800 (Silicon Graphics, Inc., California, USA), and IBM P690 (IBM Corp., New York, USA).

Design and synthesis of peptides {#s0065}
--------------------------------

The peptides were designed on the basis of the combined analyses of the proteins. The peptides were synthesized by Hangzhou Zhongtai Inc.(Hangzhou, China).

ELISA test {#s0070}
----------

Blood samples of two normal controls and nine SARS patients were provided by Beijing Plastic Surgery Hospital, Beijing Peoples' Hospital, and Beijing Tiantan Hospital. Peroxidase-conjugated mouse anti-human IgG and peroxidase-HRP (P6782) were purchased from Sigma (New Jersey, USA). Peptides (1 *μ*g/mL, in 0.5 M carbonate buffer, pH 9.6) were dispensed into a 96-well microplate (100 *μ*L/well) and then incubated at 4°C overnight. After being washed with PBS containing 0.5 M Tween-20 (PBS-T), BSA (2 mg/mL) was added up and the plates were incubated at 37°C for 1 h for blocking. The patient serum sample (10 *μ*L), diluted with 100 *μ*L of sample buffer, was added into each well and incubated at 37°C for 30 min. After being further washed with PBS-T, 100 *μ*L mouse anti-human IgG was added and incubated at 37°C for 20 min. Finally, the wells were washed with PBS-T. The reaction was observed by adding the TMB solution as substrate, after inculation at 37°C for 10 min. The reaction was stopped by adding 50 *μ*L 4 M sulphuric acid, and optical density at 450 nm (ref. 630 nm) was measured with an automatic ELISA reader (Multiskan Ascent, Finland).

Supporting Online Material {#s0080}
==========================

<http://www.gpbjournal.org/journal/pdf/GPBl(2)-07.htm>
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![The predicted distributions of GC content (A), electric charge (B), hydrophobicity (C) and secondary structure (D) in the N protein of SARS-CoV.](gr1){#f0005}

![The predicted phosphorylation sites on the N protein. We identified 33 potential phosphorylation sites in the N protein, including 22 serines, 8 threonines and 3 tyrosines. The average score of serines are significantly higher than that of the other two. The phosphorylation sites concentrate in the middle of the N protein.](gr2){#f0010}

![The similarity chart of the N protein. Based on multi-alignment of totally nineteen coronavirus N proteins, two conserved regions were found around a.a. 81-140 and a.a. 270-320 (amino acid positions are all referred to the N protein of SARS-CoV, Isolate BJ01). The arrow indicates the most conserved domain, and its sequence and amino acid position are given. In contrast, the two termini of the N protein are more variable, particularly the C- terminal. The figure was generated by Plotcon in the EMBOSS package (<http://www.hgmp.mrc.ac.uk/Software/EMBOSS/>).](gr3){#f0015}

![The possible antigenic sites of the N protein. We have predicted sixteen antigenic sites of the N protein, and found they are clustering in the middle and the C-terminal. There is a strong antigenic site (TALALLLLDR) located around Codons 218-227. In addition, another three strong antigenic sites are detected around Codons 156-166 (AATVLQLPQGT), Codons 347-363 (FKDNVILLNKHIDAYKT) and Codons 389-398 (KQPTVTLLPA).](gr4){#f0020}

![The phylogenetic tree based on nineteen coronavirus N proteins. It reveals that SARS-CoV is closer to Group 2 than to Groups 1 and 3. Abbreviations: AIBV: avian infectious bronchitis virus; BCoV: bovine coronavirus; CCoV: canine coronavirus; CECoV: canine enteric coronavirus; ECoV: equine coronavirus; FCoV: feline coronavirus; FIPV: feline infectious peritonitis virus; HCoV-OC43: human coronavirus strain OC43; HCoV-229E: human coronavirus strain 229E; MHV: murine hepatitis virus; PEDV: porcine epidemic diarrhea virus; PHEV: porcine hemagglutmating encephalomyelitis virus; PRCoV: porcine respiratory coronavirus; PTGV: transmissible gastroenteritis virus; PV: puffinosis virus; RCoV: rat coronavirus; RSCoV: Rat sialodacryoadenitis coronavirus; SARS-CoV: human severe acute respiratory syndrome-associated coronavirus isolate BJ01; TCoV: turkey coronavirus.](gr5){#f0025}

###### 

The Amino Acid Composition of the SARS-CoV N Protein

Table 1

                           Number   Percentage (%)
  ------------------------ -------- ----------------
  **Non-polar, Neutral**            
                                    
  Ala, A                   34       8.06
  Phe, F                   13       3.08
  Gly, G                   45       10.66
  Ile, I                   11       2.61
  Leu, L                   26       6.16
  Met, M                   7        1.66
  Pro, P                   31       7.35
  Val, V                   11       2.61
  Trp, W                   5        1.18
                                    
  **Total**                183      43.36
                                    
  **Polar, Neutral**                
                                    
  Cys, C                   0        0.00
  Asn. N                   25       5.92
  Gln, Q                   34       8.06
  Ser, S                   35       8.29
  Thr, T                   33       7.82
  Tyr, Y                   11       2.61
                                    
  **Total**                138      32.70
                                    
  **Polar, Positive**               
                                    
  His, H                   5        1.18
  Lys, K                   29       6.87
  Arg, R                   31       7.35
                                    
  **Total**                65       15.40
                                    
  **Polar, Negative**               
                                    
  Asp, D                   22       5.21
  Glu, E                   14       3.32
                                    
  **Total**                36       8.53

###### 

The Core Motif of SR-rich Region in the Coronavirus N Protein

Table 2

  Coronavirus                                        Core motif of SR-rich region in the N protein
  -------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------
  SARS Coronavirus BJ01                              **SR**GGSQAS**SR**SS**SRSR**GN**SR**NSTPGS **SR**[\*](#tbl2fnStar){ref-type="table-fn"}
                                                     
  Murine Hepatitis Virus                             
  Puffinosis Virus                                   
  Rat Sialodacryoadenitis Coronavirus                **SR**SG**SR**SQ**SR**
  Rat Coronavirus                                    
                                                     
  Equine Coronavirus                                 
  Bovine Coronavirus                                 
  Porcine Hemagglutinating Encephalomyelitis Virus   **SR**ST**SR**\[A/T\][\#](#tbl2fn1){ref-type="table-fn"}\[S/P\]\[**S/N**\]**R**A\[S/P\]SAG**SR**(**SR**)[†](#tbl2fn2){ref-type="table-fn"}
  HCoV-OC43                                          
                                                     
  Turkey Coronavirus                                 
  Avian Infectious Bronchitis Virus                  **S**(T)**R**AP**SR**EG **SR**{Xn}[‡](#tbl2fn3){ref-type="table-fn"}**SR**
                                                     
  Porcine Respiratory Coronavirus                    
  Transmissible Gastroenteritis Virus                
  Canine Enteric Coronavirus                         **SR**DN**SRS**\[**R/P**\] SQ**SRS**\[**R/Q**\]**SR**NRSQ**SR**{Xn}**SR**
  Canine Coronavirus                                 
                                                     
  Feline Infectious Peritonitis Virus                **SR**NN **SR**SGSQ**SR**SV**SR** NRSQ{Xn}**SR**{Xn}**SR**
  Feline Coronavirus                                 
                                                     
  Human Coronavirus 229E                             **SR**AP**SR**SQ**SR**SQ **SR**{Xn}**SR**{Xn}**SR**
                                                     
  Porcine Epidemic Diarrhea Virus                    **SR**AN**SRSRSR**{Xn} **SR**{Xn}**SR**{Xn}**SR**{Xn}**SR**

Bold letter indicates the marker SR. Normal letter indicates the amino acid between two SRs.

Square brackets indicate this position may be occupied by one of the amino acids in them.

Round brackets indicate the amino acids in them may occur in some viruses while may not in other viruses.

Curly brackets indicate amino acids between SRs, X indicates any amino acid, and subscript letter n indicates the number of amino acids between SRs.

###### 

The Predicted Antigenic Sites on the SARS-CoV N Protein

Table 3

  No.   Start Position[\*](#tbl3fnStar){ref-type="table-fn"}   Sequence            End Position
  ----- ------------------------------------------------------ ------------------- --------------
  1     52                                                     SWFTALTQ            59
  2     69                                                     RGQGVPI             75
  3     83                                                     DQIGYYR             89
  4     106                                                    SPRWYFYYLG          115
  5     118                                                    PEASLPY             124
  6     130                                                    GIVWVAT             136
  7     156                                                    AATVLQLPQGT         166
  8     218                                                    TALALLLLDR          227
  9     229                                                    NQLESKVSG           237
  10    243                                                    QGQTVTK             249
  11    267                                                    KQYNVTQ             273
  12    299                                                    YKHWPQIAQFAPSASAF   315
  13    323                                                    MEVTPSGTWLTYHGAIK   339
  14    347                                                    FKDNVILLNKHIDAYKT   363
  15    379                                                    EAQPLPQ             385
  16    389                                                    KQPTVTLLPA          398

amino acid position in the SARS-CoV N protein (BJ01)

###### 

The Synthesized Peptides Representing the N Protein of SARS-CoV and Their ELISA Result

Table 4

  Peptides Number   Start Position[\*](#tbl4fnStar){ref-type="table-fn"}   Sequence                    End Position   ELISA Result
  ----------------- ------------------------------------------------------ --------------------------- -------------- --------------
  N1                1                                                      MSDNGPQSNQRSAPRITFGGPTD     23             ++
  N21               21                                                     PTDSTDNNQNGGRNGARPKQRR      42             ++
  N35               35                                                     GARPKQRRPQGLPNNTASWFTA      56             \+
  N99               99                                                     DGKMKELSPRWYFYYLGTGPEA      120            \-
  N161              161                                                    QLPQGTTLPKGFYAEGSRGGSQ      182            +++
  N177              177                                                    SRGGSQASSRSSSRSRGNSRNS      198            ++
  N196              196                                                    RNSTPGSSRGNSPARMASGGGE      217            \-
  N215              215                                                    GGETALALLLLDRLNQLESKVSGKG   239            ++
  N245              245                                                    QTVTKKSAAEASKKPRQKRTATKQ    268            ++
  N258              258                                                    KPRQKRTATKQYNVTQAFGRRG      279            \+
  N355              355                                                    NKHIDAYKTFPPTEPKKDKKKK      376            ++
  N371              371                                                    KDKKKKTDEAQPLPQRQKKQ        390            +++
  N385              385                                                    QRQKKQPTVTLLPAADMDDFSRQ     407            ++
  N401              401                                                    MDDFSRQLQNSMSGASADSTQA      422            \-

amino acid position in the SARS-CoV N protein (BJ01)

###### 

The Four Substitutions in the N Protein of SARS-CoV

Table 5

  Nt Position in BJ01   a.a. Position in the ORF   a.a. (Ratio)   Synonymous Substitution
  --------------------- -------------------------- -------------- -------------------------
  28,519                140                        L(16)/W(1)     No
  28,520                140                        L(17)          Yes
  28,560                154                        N(16)/Y(1)     No
  28,677                193                        G(16)/C(1)     No

[^1]: These authors contributed equally to this work.
